COVID Vaccine Developers May Want To Pivot To Symptom Prevention

Clinical Research News | Vaccine developers may want to consider designing formulations intended to prevent symptoms rather than infection, which the COVID-19 pandemic has demonstrated can be hard to do with any long-lasting effect.